1388892-70-3

Basic information

• Product Name: 4-N-(5-bromo-6-ethylthieno[2,3-d]pyrimidin-4-yl)-1-N,1-N-dimethylcyclohexane-1,4-diamine
• Synonyms: 4-N-(5-bromo-6-ethylthieno[2,3-d]pyrimidin-4-yl)-1-N,1-N-dimethylcyclohexane-1,4-diamine
• CAS NO: 1388892-70-3
• Molecular Weight: 383.355
• Mol File: 1388892-70-3.mol

Chemical Properties

• CAS DataBase Reference: 4-N-(5-bromo-6-ethylthieno[2,3-d]pyrimidin-4-yl)-1-N,1-N-dimethylcyclohexane-1,4-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-N-(5-bromo-6-ethylthieno[2,3-d]pyrimidin-4-yl)-1-N,1-N-dimethylcyclohexane-1,4-diamine(1388892-70-3)
• EPA Substance Registry System: 4-N-(5-bromo-6-ethylthieno[2,3-d]pyrimidin-4-yl)-1-N,1-N-dimethylcyclohexane-1,4-diamine(1388892-70-3)

Safety Data

• Hazardous Substances Data: 1388892-70-3(Hazardous Substances Data)

Upstream product

• 1388891-99-3 4-N-[6-ethylthieno[2,3-d]pyrimidin-4-yl]-1-N,1-N-dimethylcyclohexane-1,4-diamine 

Downstream Products

• 1388892-78-1 4-N-[5-(1-benzofuran-2-yl)-6-ethylthieno[2,3-d]pyrimidin-4-yl]-1-N,1-N-dimethylcyclohexane-1,4-diamine 

Relevant articles and documents

IRAK INHIBITORS AND USES THEREOF

The present invention relates to compounds and methods useful for inhibiting one or more interleukin-l receptor-associated kinases ("IRAK"). In some embodiments, a provided compound inhibits IRAK-1 and IRAK-4. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.